Willows Referral Service
Locum Internal Medicine Clinician required
During 2010 Willows Referral Service has opportunities for part-time Internal Medicine locum cover. The successful applicant(s) should either hold an RCVS, European or American Diploma (or equivalent) or have undertaken Residency training and be ready to take their final Diploma examinations. Candidates must share our aim of providing the best possible levels of care for clients, their pets and for referring veterinary surgeons.
We have an excellent team of support staff who give our clinicians the opportunity to concentrate on their clinical caseload and to work in a pleasant, supportive and good humoured atmosphere. Facilities include a superbly equipped intensive care unit, kennelling for over 100 in-patients, all-new GE imaging equipment, including 1.5T MRI, top-end 16 slice CT with in-room CT fluoroscopy, two general digital X-ray rooms, mobile image intensifier, high-end ultrasound and Olympus video endoscopy. Our medicine clinicians, Jane Eastwood DSAM and Kirsty Roe DipACVIM, work alongside specialists in the disciplines of soft tissue surgery, neurology, ophthalmology, orthopaedics, imaging and anaesthesia, and our philosophy is very much one of friendly co-operation between clinicians in every specialism.
For further information about Willows internal medicine service please visit http://www.willows.uk.net/en-GB/specialist-services/specialisms/internal-medicine
If you are interested and would like an informal chat about the position, please contact Jane Eastwood on 0121 712 7070
Willows Veterinary Centre & Referral Service, Solihull, West Midlands www.willows.uk.net
See attachment for info on discounted rates for BSAVA manuals at pre congress meeting
Best wishes
Yvonne
Free plasma metanephrines – a novel diagnostic approach for the diagnosis of pheochromocytoma in dogs
The Royal Veterinary College is investigating whether an increased plasma metanephrine concentration can be used to identify pheochromocytomas in dogs. We hope this will provide a useful indicator for pheochromocytomas, which are otherwise challenging to diagnose and our preliminary data suggests that plasma metanephrine concentrations increase in affected dogs.
EDTA plasma samples are being submitted for metanephrine measurement by High Pressure Liquid Chromatography (HPLC) and we also plan to validate a radioimmunoassay for metanephrine measurement.
We would welcome EDTA plasma samples from dogs undergoing investigation of adrenal masses, especially if pheochromocytoma is strongly suspected. The full cost of this test will be covered by the project grant and HPLC results are usually available within 7 days.
For further information or to discuss submitting a sample for analysis, please contact:
Ruth Gostelow BVetMed (Hons) MRCVS
Senior Clinical Training Scholar in Small Animal Internal Medicine
Email: rgostelow@rvc.ac.uk
Or call the RVC Clinical Investigations Centre on 01707 666605
Fellow investigator: Harriet Syme BSc BVetMed PhD MRCVS D-ACVIM D-ECVIM
Other projects listed in the SAMSOC Wiki
Thought i would let you all know, that we have now reach the milestone of 100 SAMSOC members registered on the site.
The commitee is now starting to look for new ideas to develop within the site that will benefit members. Current features include - the forum, a wiki for listing projects that are recruiting cases and a media section for interesting radiographs/case material.
If you have any good ideas please contact us and we will see what we can do
All the best and see you tommorow
Ian
PS- There are still some members have yet to register on the site. So if you know one of them give them a nudge.
Hi all,
Just wanted to thank everyone again who came along to the satelitte meeting. I am sure you will agree it was a great day and we heard some interesting talks.
The results for the case report competition are below - Much to the relief of the presenters i forgot my camera so there is no photo to follow.
1st Place - Deoxycorticosterone-producing adrenal carcinoma causing signs of mineralocorticoid excess and hypokalaemic myopathy in a dog
Ruth Gostelow (RVC - Medicine resident )
Second Place - Abdominal mycetoma in a dog caused by Scedosporium apiospermum Rosanne Jepson (RVC - Medicine Resident)
3rd place - Colonic candidiasis in a dog - Caroline Kisielewicz (Glasgow University - Medicine Resident)
4th place - Four cases of feline hyperprogesteronism - Natasha Hetzel (Bristol University - Medicine Resident)
In total we had 10 excellent submission from practioners and residents - whioch ave the commitee a nice but difficult task of slecting the top 3 . infact we expanded it to four. We hope to secure funding for the competition, so keep the competition in mind when you are on clinics.
Other news is that the commmitee has had alittle re shuffle
Marge Chandler and Clive Elwood have stepped down. Again the Commitee would like to thank them for their hard work and input over the last 4-5 years.
New members of the commitee
Mark Dunning - has joined the program commitee
David Walker - has taken over the PR role from me
My role will change and I will be keeping an eye on the website and hopefully coming up with some new ideas to make it more interesting ( let me know if you have any) and focusing on the antibiotic usage project.
All the best
Hi everyone
Jon Wray presented a seminar on writing a CERTSAM casebook at the meeting this year and he has kindly agreed to allow us to post the notes for this session in the media section of the SAMSOC website. This document is accessible to all SAMSOC members and is password protected. So if you would like the access the document please contact me by the vetsurgeon conversation facility and i will provide you with the password
As a reminder
The following projects have been posted within the SAMSOC Wiki - full details of the projects can be found in the wiki. I am please to report that I am aware of case recruitemnts being made as a consequence of the Wiki. So if you would like to post a project ( takes under 10 mins) please feel free and if you need any help let me know
Projects on going at the moment
Metanephrine and normetanephrine are catecholamine metabolites produced by the cells of the adrenal medulla and detection of an increased plasma metanephrine concentration is the biochemical test of choice...
Genetic Basis of Endocrine Disease in Dogs
As part of the LUPA initiative ( http://www.eurolupa.org ), the Royal Veterinary College, University of London and the Universities of Manchester and Uppsala are collaborating to investigate the genetic...
Exocrine Pancreatic insufficiency (EPI) Treatment Study
Exocrine Pancreatic insufficiency (EPI) Treatment Study Aran Mas DVM MRCVS P-J.M.Noble BSc BVM&S PhD MRCVS, A.J.German BVSc PhD CertSAM DipECVIM-CA MRCVS EPI is a common condition in dogs with early...
Congenital PSS in Birman Cats - DNA Project
We are currently looking at the predisposition of Birman cats to congenital portosystemic shunts. The project is being run by myself and Professor Tim Gruffydd-Jones at the Feline Centre Bristol in conjunction...
Feline Chronic Kidney Disease: Use of oral phosphate binders
As part of ongoing research into Feline Chronic Kidney Disease (CKD) at the Royal Veterinary College, The Clinical Investigation Centre (CIC) is working with an animal health company to verify the efficacy...
2009
SAMSoc Travel Scholarship 2011
The award will be presented at the pre-BSAVA SAMSoc meeting on 30th March 2011. The award is kindly sponsored by Pfizer.
thought i would refresh everyones memories of the projects ( looking to recruit samples, cases or complete questionaires) . Listed in the SAMSoc Wiki section. More detail can be found on the project you may find interesting including contacts etc within the Wiki.
If you have a project that you would like to list please post away or contact me via a vetsurgeon conversation link or by e mailing me directly at iab@vetspecialists.co.uk
all the best
Efficacy of masitinib in dogs with steroid-resistant inflammatory bowel disease
Fabio Procoli DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine
Karin Allenspach Dr.med.vet. PhD DECVIM-CA MRCVS, Senior Lecturer in Small Animal Internal Medicine
Masitinib is a protein tyrosine kinase inhibitor licensed for the use in dogs with mast cell tumours, where it has proven efficacy. There also reports that this drug can decrease inflammation in people with several immune mediated disorders, including IBD.
The Veterinary Clinical Sciences at the Royal Veterinary College is performing a clinical trial to evaluate the clinical efficacy of masitinib as a sole treatment for canine IBD in steroid-refractory cases over a period of 8 weeks.
Further details can be found in the SAMSOC wiki.
Other projects listed
Exocrine Pancreatic insufficiency (EPI) Treatment Study Aran Mas DVM MRCVS P-J.M.Noble BSc BVM&S PhD MRCVS, A.J.German BVSc PhD CertSAM DipECVIM-CA MRCVS
We are currently looking at the predisposition of Birman cats to congenital portosystemic shunts. The project is being run by Angie Hibbert and Professor Tim Gruffydd-Jones at the Feline Centre Bristol
Stijn Neissen RVC
Hi ,
I appreciate that this is a advertsiement for a soft tissue society , but as i was approached by a member of the commitee as this years programm does have potential interest for a medic. Namely Congenital and Herediatary disease.
If you are interested please contact avstsadmin@fsmail.net for detail
AVSTS Autumn Meeting 2010, 1st – 2nd October
Congenital and Hereditary Disease in Dogs and Cats
FRIDAY 1
st OCTOBER
9.30-10.00 Registration & Coffee
10.00-10.45 Heritable and Congenital Disease – David Sargan A Geneticist’s View
10.45-11.30 Ethics of the Management of Diseases Siobhan Mullan Present at Birth – Individual versus Population
11.30-11.50 Coffee
11.50-12.50 Surgical Treatment of Congenital and Hereditary Disease in Children
12.50-1.50 Lunch
1.50-2.25 The Way Forward? Michael Herrtage
2.25-2.40
Panel Discussion:David Sargan, Siobhan Mullan and Michael Herrtage
2.40-4.15 Brachycephalic Diseases
2.40-3.30 Brachycephalics: Gerhard Oechtering
Trapped in Man-Made Misery? Turbinate Ablation in BAOS
3.30-4.00 Brachcephalic Airway Obstruction Syndrome Rob White
4.00-4.15
Panel Discussion:
Gerhard Oechtering and Rob White
4.15-4.30 Coffee
4.30-5.30 Urogenital Disease and Cancer
4.30-4.50 Not Zipped-Up: Treatment of Extreme Jane Ladlow
Hypospadias in a Dobermann, plus Review of Hypospadias
4.50-5.10 A (Chamber) Potpourri of Peter Holt
Congenital Urinary Incontinence
5.10-5.30 Cancer in the Genes: Jane Dobson
Histiocytic Sarcoma in Flatcoated Retrievers and LUPA
5.30 Close
Dear Members,
The 2011 SAMSOC satellite meeting programme is soon to be completed.
Please do yourself a favour and keep your diaries free on:
WEDNESDAY 30th MARCH 2011.
Controversy will be at the very heart of this exhilerating day. Join us and be consumed by one of the talks called:
"Pathologists are from Mars and Clinicians are from Venus – will they ever really understand one another?"
More programme information to follow; one guarantee we can give you at this stage: you will feel seriously left out if you miss it.
SAMSoc Programme Committee 2011
Petplan Charitable Trust PhD Study to Investigate Feline Infectious Peritonitis-Specific Nucleotide Motifs
A three-year study, leading to a PhD, is being funded by the Petplan Charitable Trust and is available to commence on 1st February 2011 in the School of Veterinary Sciences, Langford at the University of Bristol. The aim of the project is to define nucleotide sequence motifs in feline coronaviruses (FCoVs) associated with feline infectious peritonitis (FIP) and to then develop a diagnostic test for the confirmation of FIP. The applicant will gain extensive experience in molecular-based techniques and bioinformatic analysis. Furthermore, the applicant will receive training in the design, conduct and presentation of research. Practical work will be done in the School of Veterinary Sciences, Langford and the School of Cellular and Molecular Medicine, Bristol. The work will be jointly supervised by Professor Stuart Siddell and Drs Chris Helps and Séverine Tasker, supported by collaborators both within the University of Bristol and in other Universities. Good computer skills are essential, and some experience of molecular research and feline medicine is desirable. The successful applicant will have a high level of literacy and numeracy, good organisation skills and a willingness to learn and develop research skills to a high standard. The successful applicant will also have excellent communication skills and confidence in making contact with cat owners and veterinary surgeons.
Applicants must possess, or expect to obtain, a first class, or good upper second class, degree in a biological related subject, or a degree in a veterinary science, and be able to demonstrate a clear interest in FIP. This project is available to citizens of a number of European countries (including the UK) who have been resident in the UK for a period of 3 years or more.
Informal enquiries about the project are encouraged and can be made to Dr Séverine Tasker (email: s.tasker@bristol.ac.uk).
To apply, please send a CV, cover letter, and the names and addresses of two referees to Alison Foxwell, Head of Department’s Office, School of Veterinary Sciences, Langford House, Langford, North Somerset, BS40 5DU (email: cvs-hod-office@bristol.ac.uk), quoting reference SCH/10/09, by December 15th 2010.
Fabio Procoli DMV MRCVS, Senior Clinical Training Scholar in Small Animal Internal Medicine RVC
The Royal Veterinary College
To apply, please send a CV, cover letter, and the names and addresses of two referees to Alison Foxwell, Head of Department’s Office, School of Veterinary Sciences, Langford House, Langford, North Somerset, BS40 5DU (email: cvs-hod-office@bristol.ac.uk), quoting reference SCH/10/09, by December 15th 2010
The new oncology department has a dedicated chemotherapy room, access to a variety of chemotherapy drugs and a fully equipped operating theatre – offering soft tissue and orthopaedic surgery services for surgical oncology cases.
The department also has access to high frequency ocular ultrasound, magnetic resonance (MRI), and computed tomography (CT) scan equipment.
The service will be led by residency-trained clinician in Small Animal Oncology, Nina Vigevani DVM MRCVS.
She graduated in 2019 from the University of Milan, completed a rotating internship and worked in general practice in Milan, before moving to the UK to start on an oncology internship at a referral practice in the South of England.
Prior to moving to Chestergates, she completed her Residency in Small Animal Oncology at the University of Liverpool.
To refer a case: https://chestergates.org.uk/referral-services.
This allows patients to try the drug at lower cost, before progressing to the 30ml bottle for ongoing treatment.
Samantha Taylor, RCVS Recognised Specialist in Feline Medicine said: “It’s great we now have the option to prescribe the smaller 12ML bottle for starting cats on Senvelgo, as it means we don’t have to worry about wasting a 30ml bottle if it becomes evident that the cat requires insulin in the first couple of weeks.”
https://senvelgo.co.uk
David, Appleton Professor in Equine Surgery, University of Florida (pictured, left), says that despite considerable progress since the 1970's, largely through improved understanding of the diseases involved, diagnostic methods, surgical equipment and materials, and specialised training of surgeons, lingering problems remain and need to be addressed at all levels, not just by surgeons.
He said: “The current high cost of colic surgery can deny many horses a life-saving procedure.
"Pessimism is likely the product of past failures and overemphasis of treatments that are inappropriate or misdirected.
"Delays in referral might seem minor but have devastatingly harmful effects on outcome.
"Owners, primary care veterinarians, and surgeons need to establish an approach to colic based on teamwork, education, and rejection of myths that are widely promulgated.
"I will be looking at the key elements of progress and how they can be applied for future success.”
Professor Scott Weese (pictured right) is Director of the Centre for Public Health and Zoonoses at the University of Guelph.
He will present: "Misconceptions, Myths and Dogmas: moving past old barriers to optimise antimicrobial use in horses", which will challenge the audience to think about what they do with antibiotics and why, with the aim of introducing practical steps to optimise antimicrobial use, leading to improved patient outcomes, easier treatment and minimisation of negative consequences.
Scott said: “We do a lot of things simply because we’ve done them, not because they work or make sense, and we need to look at what we’re doing and the available evidence.
"I will discuss some well-established dogmas that don’t actually make sense, cover some common questions and misconceptions about antibiotic use, and try to help us advance how we use these life-saving drugs that, to some degree, are a non-renewable resource.”
Scott will also be presenting a talk about sampling on the Friday in the antimicrobial stewardship session, with the aim of getting everyone thinking about how we make antibiotic decisions: “There’s a lot of emphasis on submitting cultures, but if we submit bad samples or can’t interpret them, it’s at best a waste of money and at worst can harm patients.”
Book before 6th August to take advantage of early bird prices for BEVA members of £599 for a three-day pass for vets (normal price £699) and £225 for vet nurses (normal price £273) (with concessionary rates available for those in their first three years of graduation or earning less than £25,000).
Day tickets and practice passes are also available.
Early bird rates and practice passes are available until 6 August 2025.
http://www.bevacongress.org
Zenrelia is a new JAK inhibitor which Elanco says provides visible itch relief which lasts 24 hours, from the first dose.1
The company points to a head-to-head study with over 330 dogs across 25 vet clinics, in which Zenrelia was shown to get nearly 50% more itchy dogs back to normal than Apoquel (oclacitinib).1
Elanco says its once-daily dosing may also improve treatment compliance over twice-daily alternatives.
The company also says that Zenrelia has a cost benefit too, presumably meaning it's cheaper than alternatives.
Zenrelia can be given long term with commonly used medications, including vaccines, antibiotics, parasiticides and NSAIDs.
Elanco UK & Ireland General Manager Matthew Frost said: “With this treatment, we’re looking at happier dogs and their owners, and a more rewarding experience for vets.”
www.zenrelia.co.uk
Reference
For the study, researchers from the RVC, University of Edinburgh and Scotland’s Rural College analysed data from the RVC’s VetCompass Programme on a random sample of 2,440 nail clipping cases taken from over 2 million dogs under UK primary veterinary practice care during 2019, 5.64% of UK dogs (over one in twenty dogs) were found to have had their nails clipped at least once as part of their primary veterinary care each year.
The nail clipping was the primary reason for attending the veterinary visit for more than half (59.40%) of those dogs.
The most cited clinical reasons for nail clipping veterinary visits were overgrown and/or ingrown nails (12.66%) and broken claws or dewclaws (8.84%).
Of the breeds that were most likely to present for nail-clipping, 13.29% of chihuahuas were clipped each year, 12.58% of beagles, 11.98% of greyhounds and 9.36% of pugs.
Dog breeds with a skull shape that deviated from a typical medium-length skull in either direction also had a higher risk of needing nail clipping.
Flat-faced dogs breeds (e.g. pugs, French bulldogs, shih tzus) were 1.67 times more likely to have their nails clipped, while breeds with long faces (e.g. greyhound, whippet) were 1.32 times more likely to have their nails clipped, compared to breeds with a medium length skull (e.g. Labrador retriever, English springer spaniel).
Dog breeds with shortened and often twisted legs (chondrodystrophic breeds) were also 1.44 times more likely to have their nails clipped compared to dog breeds with straight legs.
Age and body weight also affected a dog’s chances of undergoing nail clipping.
Young dogs aged between 1 to 2 years were the most likely to have nail clipping procedures.
Smaller dogs weighing less than 10.00 kg had higher odds of overgrown nails compared to larger dogs weighing 40.00 kg or more.
The researchers say that frequency of nail clipping in primary veterinary care indicates the need for comprehensive teaching of canine nail care in veterinary and veterinary nursing education, as well as proactive veterinary monitoring, nail care protocols and owner education.
Dr Dan O’Neill, Associate Professor of Companion Animal Epidemiology at the RVC and co-author of the paper, said: “This new VetCompass study shows that some dog breeds have more than twice the need to have their nails clipped compared to other breeds.
"This highlights just how distinct humanity has made each dog breed and suggests we are getting close to the time when we should no longer consider all dog breeds as even being the same species.”
Dr Lavin Ahmed, Veterinary Surgeon, President of Protecting Animals in Kurdistan Organization (PAKO) and lead author of the study, said: “When I was first offered nail clipping by RVC VetCompass as my MSc research topic, I honestly underestimated its significance.
"It seemed like just another routine procedure that we all do every day in veterinary practice.
"However, reading the clinical records made it clear that nail care is more than just a trivial grooming procedure but is a genuine welfare issue that deserves much more attention in both veterinary training and owner education.”
The scholarships are designed to support veterinary surgeons who demonstrate exceptional commitment to professional growth and a passion for improving patient outcomes.
Each award covers the tuition fee for the 12-month programmes, including both online learning and practical training sessions.
Applications close for the Small Animal Soft Tissue Scholarship on 15th August 2025, and the Small Animal Medicine Scholarship on the 5th September 2025.
Improve says shortlisted applicants will be assessed based on professional motivation, career aspirations, and commitment to the profession.
https://subscriptions.improveinternational.com/small-animal-medicine-scholarship-2025
https://subscriptions.improveinternational.com/small-animal-soft-tissue-surgery-scholarship-2025
They say that the free system offers an easy way for veterinary practices to improve client service, streamline workflows, and enhance animal welfare.
Boop uses AI and computer vision to auto-populate vaccination details and capture things like microchip numbers, to ensure certificates are positively identifiable and compliant with the RCVS 10 principles of certification and electronic signing guidance.
Pet owners can then store and access digital vaccination certificates on their mobile phone through the Boop app, where they can also look-up chip details, up to 30% of which are not properly registered.
The app also lets owners share vaccination certificates easily with boarding and day care establishments via email or whatsapp.
Charlie said: “Boop brings a vaccination record service fit for 2025, enabling vets to add more value to their vaccination service and owners to care better for their pet.
"By linking to the microchip, vets can be confident that every record belongs to the right pet—making care safer, more accurate, and more convenient.”
Once signed up, practices can start issuing digital vaccination certificates immediately, without changing their existing PMS or workflows.
www.booppet.app/vets
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
References
The working group, which is led by Gudrun Ravetz, IVC's Group Chief Medical Officer, has been tasked with developing evidence-based, sustainable prescribing practices that protect animal health while safeguarding the planet.
The group comprises experts from within IVC Evidensia’s network who will collaborate with industry and academic partners including Vetoquinol, IDEXX, ESCCAP, and MSD Animal Health to deliver research, education, and practical tools for veterinary teams both inside and outside of IVC Evidensia practices.
Gudrun said: “We’re proud to be investing in this work and setting an example for the profession.
"Responsible parasiticide use is not just a clinical issue, it’s a sustainability imperative.”
Photo: www.depositphotos.com
PhotonUVC Vet is a non-contact treatment which emits low dose ultraviolet C light at a targeted area.
Photon Therapeutics says the device kills bacteria, viruses, fungi and other infecting organisms while being safe to host tissues.
Other claimed benefits of the device are that it avoids client compliance issues associated with eye-drops, it eliminates the need for antibiotic eye drops, and it is very simple to learn how to use.
The device costs £4,995.
To explain more about The PhotonUVC Vet, Dr. Simon Dean. MBChB, MSc, FRANZCO, FBCLA Chief Scientific Officer at Photon Therapeutics, and Dr. Mark Leddy BVSc, MBA, CEO, will be delivering a CPD presentation at the Exhibitor Showcase Theatre 3: "5 Amazing Seconds – A New Transformative Treatment for Corneal Infections", on Thursday 14th November at 3pm.
There is also a launch event reception at the stand from 16.15 to 18.15 on Thursday 14 November.
https://photon-therapeutics.com/